Brief: Pacira Biosciences Q1 Adjusted EBITDA USD 44.6 Million Vs. IBES Estimate USD 45.3 Million
07/05/2024 21:00
May 07 (Reuters) - Pacira Biosciences Q1 adjusted net income USD 31.1 million vs. IBES estimate USD 30.7 million. * Q1 cash & investments USD 325.9 million * Q1 net income USD 9 million * Q1 revenue USD 167.1 million vs. IBES estimate USD 165.4 million
Recent news on Pacira Biosciences
See all newsBrief: Pacira Biosciences Inc - Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote "For" All Of Pacira's Director Nominees
Brief: Pacira Biosciences Urges Stockholders To Vote "For" Election Of Pacira's Nominees On Blue Proxy Card
Brief: Doma Perpetual Urges Pacira Biosciences Shareholders To Judge Sale Price Adequacy
Brief: Doma Perpetual Capital Management Calls For Removal Of Pacira CEO And Strategic Sale
Brief: Pacira Biosciences Sends Letter To Stockholders Reiterating Superior Qualifications Of Its Board Nominees